Open Access

N6‑methyladenine RNA modification and cancer (Review)

  • Authors:
    • Jun Yang
    • Junwen Chen
    • Xiang Fei
    • Xia Wang
    • Kefeng Wang
  • View Affiliations

  • Published online on: June 16, 2020     https://doi.org/10.3892/ol.2020.11739
  • Pages: 1504-1512
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

N6‑methyladenosine (m6A) in messenger RNA (mRNA) is regulated by m6A methyltransferases and demethylases. Modifications of m6A are dynamic and reversible, may regulate gene expression levels and serve vital roles in numerous life processes, such as cell cycle regulation, cell fate decision and cell differentiation. In recent years, m6A modifications have been reported to exhibit functions in human cancers via regulation of RNA stability, microRNA processing, mRNA splicing and mRNA translation, including lung cancer, breast tumor and acute myeloid leukemia. In the present review, the roles of m6A modifications in the onset and progression of cancer were summarized. These modifications display an oncogenic role in certain types of cancer, whereas in other types of cancer they exhibit a tumor suppressor role. Therefore, understanding the biological functions performed by m6A in different types of tumors and identifying pivotal m6A target genes to deduce the potential mechanisms underlying the progression of cancer may assist in the development of novel therapeutics.

Related Articles

Journal Cover

August-2020
Volume 20 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Yang, J., Chen, J., Fei, X., Wang, X., & Wang, K. (2020). N6‑methyladenine RNA modification and cancer (Review). Oncology Letters, 20, 1504-1512. https://doi.org/10.3892/ol.2020.11739
MLA
Yang, J., Chen, J., Fei, X., Wang, X., Wang, K."N6‑methyladenine RNA modification and cancer (Review)". Oncology Letters 20.2 (2020): 1504-1512.
Chicago
Yang, J., Chen, J., Fei, X., Wang, X., Wang, K."N6‑methyladenine RNA modification and cancer (Review)". Oncology Letters 20, no. 2 (2020): 1504-1512. https://doi.org/10.3892/ol.2020.11739